Scientists validate new lab test platform for blood biomarkers of Alzheimer's disease
University of Pittsburgh scientists have independently validated a new blood test platform that can simultaneously measure more than a hundred biomarkers of Alzheimer’s disease. The platform might improve clinicians’ ability…